Perforin-mediated target-cell death and immune homeostasis

The granule exocytosis pathway of cytotoxic lymphocytes is crucial for immune surveillance and homeostasis. The trafficking of granule components, including the membrane-disruptive protein perforin, to the immunological synapse leads to the delivery of granule proteases (granzymes) into the target cell and its destruction through apoptosis. Several independent molecular abnormalities associated with defects of either granule trafficking or perforin function can cause cytotoxic lymphocyte dysfunction. In humans, inherited perforin mutations result in severe immune dysregulation that manifests as familial haemophagocytic lymphohistiocytosis. This Review describes recent progress in defining the structure, function, biochemistry and cell biology of perforin.

[1]  J. Harty,et al.  Influence of effector molecules on the CD8(+) T cell response to infection. , 2002, Current opinion in immunology.

[2]  J. D. Young,et al.  Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells , 1986, The Journal of experimental medicine.

[3]  I. Hirono,et al.  A pore-forming protein, perforin, from a non-mammalian organism, Japanese flounder, Paralichthys olivaceus , 2004, Immunogenetics.

[4]  R. Zinkernagel,et al.  Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus , 1998, The Journal of experimental medicine.

[5]  R. Clementi,et al.  Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. , 2001, Blood.

[6]  P. Schwartzberg,et al.  Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation , 2003, Nature Cell Biology.

[7]  R. Clementi,et al.  SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. , 2005, Blood.

[8]  T. Kirchhausen,et al.  An emergency response team for membrane repair , 2005, Nature Reviews Molecular Cell Biology.

[9]  H. Hengartner,et al.  Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. , 1996, Current opinion in immunology.

[10]  G. Janka Familial and acquired hemophagocytic lymphohistiocytosis , 2006, European Journal of Pediatrics.

[11]  M. Smyth,et al.  Perforin is a major contributor to NK cell control of tumor metastasis. , 1999, Journal of immunology.

[12]  S. Nutt,et al.  IL-21 Induces the Functional Maturation of Murine NK Cells 1 , 2004, The Journal of Immunology.

[13]  P. Moore,et al.  Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. , 2006, Immunity.

[14]  R. Clementi,et al.  A proportion of patients with lymphoma may harbor mutations of the perforin gene. , 2004, Blood.

[15]  R. Schneppenheim,et al.  A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. , 2004, Blood.

[16]  H. Virgin,et al.  Natural Killer Cells Utilize both Perforin and Gamma Interferon To Regulate Murine Cytomegalovirus Infection in the Spleen and Liver , 2005, Journal of Virology.

[17]  W. Gahl,et al.  Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. , 1999, Molecular genetics and metabolism.

[18]  A. Fischer,et al.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome , 2000, Nature Genetics.

[19]  M. Aricò,et al.  A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? , 2005, Haematologica.

[20]  S. Korsmeyer,et al.  Cell death induced by granzyme C. , 2003, Blood.

[21]  A. Krensky,et al.  NK Cells Use Perforin Rather than Granulysin for Anticryptococcal Activity1 , 2004, The Journal of Immunology.

[22]  J. Trapani,et al.  Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ , 2002, The Journal of experimental medicine.

[23]  R. Clementi,et al.  Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. , 2002, Blood.

[24]  M. Simon,et al.  Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent onthe FasL/Fas pathway , 2003, European journal of immunology.

[25]  A. Krensky,et al.  Granulysin, a Cytolytic Molecule, Is Also a Chemoattractant and Proinflammatory Activator 1 , 2005, The Journal of Immunology.

[26]  R. Ahmed,et al.  CD8-Mediated Protection against Ebola Virus Infection Is Perforin Dependent , 2005, The Journal of Immunology.

[27]  E. Orilieri,et al.  Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function. , 2006, Blood.

[28]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[29]  J. Harty,et al.  Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. , 2003, Immunity.

[30]  L. Notarangelo,et al.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. , 2005, Blood.

[31]  A. Fischer,et al.  Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis , 2005, Immunological reviews.

[32]  G. Griffiths,et al.  Lytic granules, secretory lysosomes and disease. , 2003, Current opinion in immunology.

[33]  J. Cowan,et al.  Solution structure of a synthetic lytic peptide: the perforin amino terminus. , 1998, Chemistry & biology.

[34]  H. Hennies,et al.  Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. , 2005, Human molecular genetics.

[35]  E. Podack,et al.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity , 1986, Cell.

[36]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[37]  G. Fritzsch,et al.  Transients of perforin pore formation observed by fluorescence microscopic single channel recording. , 1990, The EMBO journal.

[38]  C. Peters,et al.  Cytotoxic T Lymphocytes from Cathepsin B-deficient Mice Survive Normally in Vitro and in Vivo after Encountering and Killing Target Cells* , 2006, Journal of Biological Chemistry.

[39]  J. Lieberman,et al.  Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. , 2005, Immunity.

[40]  Marion E. Schneider,et al.  Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. , 2001, American journal of human genetics.

[41]  M. Simon,et al.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. D. Young,et al.  The lymphocyte pore-forming protein perforin is associated with granules by a pH-dependent mechanism. , 1989, Immunology letters.

[43]  P. Lu,et al.  Structure and function of human perforin , 1988, Nature.

[44]  R. Ahmed,et al.  A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection , 1999, Journal of Virology.

[45]  M. Terasaki,et al.  Coping with the inevitable: how cells repair a torn surface membrane , 2001, Nature Cell Biology.

[46]  J. Trapani,et al.  A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. , 2005, Blood.

[47]  M. Smyth,et al.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. , 2001, Blood.

[48]  R. Clementi,et al.  Atypical features of familial hemophagocytic lymphohistiocytosis. , 2004, Blood.

[49]  W. Grossman,et al.  Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8. , 2005, Blood.

[50]  A. Filipovich,et al.  Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis , 2004, Journal of Medical Genetics.

[51]  R. Clementi,et al.  Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation. , 2006, The Journal of pediatrics.

[52]  K. Elkon,et al.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. , 2000, The Journal of clinical investigation.

[53]  Timothy J. Ley,et al.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.

[54]  A. Heck,et al.  Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells. , 2004, Molecular biology of the cell.

[55]  N. Barnes,et al.  Familial haemophagocytic reticulosis. , 1968, Archives of disease in childhood.

[56]  M. Smyth,et al.  Functional Analysis of Granzyme M and Its Role in Immunity to Infection1 , 2005, The Journal of Immunology.

[57]  J. Trapani,et al.  Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation , 2000, The Journal of experimental medicine.

[58]  A. Morimoto,et al.  Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: analysis of 96 patients , 2005, European Journal of Pediatrics.

[59]  D. Green,et al.  Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax , 2000, The Journal of experimental medicine.

[60]  J. Trapani,et al.  A Central Role for Bid in Granzyme B-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[61]  G. Klein,et al.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.

[62]  J. Trapani,et al.  Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma , 2000, The Journal of experimental medicine.

[63]  J. Whisstock,et al.  Cationic Sites on Granzyme B Contribute to Cytotoxicity by Promoting Its Uptake into Target Cells , 2005, Molecular and Cellular Biology.

[64]  M. Devidas,et al.  Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group , 2006, Leukemia.

[65]  N. Rochel,et al.  Negative cooperativity exhibited by the lytic amino-terminal domain of human perforin: implications for perforin-mediated cell lysis. , 1996, Chemistry & biology.

[66]  P. Henkart,et al.  Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation , 2002, The Journal of experimental medicine.

[67]  L. Machesky,et al.  Rab27a Is Required for Regulated Secretion in Cytotoxic T Lymphocytes , 2001, The Journal of cell biology.

[68]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[69]  E. Paz-Artal,et al.  Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection. , 2006, Haematologica.

[70]  J. Lieberman,et al.  Nuclear war: the granzyme A-bomb. , 2003, Current opinion in immunology.

[71]  W. Clark The hole truth about perforin , 1994, Nature.

[72]  R G Miller,et al.  A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. , 1999, Journal of immunology.

[73]  P. Henkart,et al.  Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin , 1995, Journal of Experimental Medicine.

[74]  P. Marrack,et al.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. , 2004, Blood.

[75]  A. Filipovich,et al.  Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. , 2005, The Journal of clinical investigation.

[76]  C. Griscelli,et al.  A syndrome associating partial albinism and immunodeficiency. , 1978, The American journal of medicine.

[77]  E. Jaffe,et al.  Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. , 2004, Blood.

[78]  W. Almers,et al.  Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells , 1990, The Journal of cell biology.

[79]  A. Fischer,et al.  Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. , 2005, Blood.

[80]  R. Clementi,et al.  Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis , 2001, Journal of medical genetics.

[81]  J. Trapani Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. , 1998, International review of cytology.

[82]  K. Ebnet,et al.  Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[83]  L. Dekker,et al.  Crystal structure of the C2 domain from protein kinase C-delta. , 1998, Structure.

[84]  Judy Lieberman,et al.  HMG2 Interacts with the Nucleosome Assembly Protein SET and Is a Target of the Cytotoxic T-Lymphocyte Protease Granzyme A , 2002, Molecular and Cellular Biology.

[85]  J. D. Young,et al.  Perforin: structure and function. , 1995, Immunology today.

[86]  Piero Musiani,et al.  Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. , 2003, The Journal of clinical investigation.

[87]  J. D. Young,et al.  Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules , 1986, The Journal of experimental medicine.

[88]  J. D. Young,et al.  Perforin binding to cells and lipid membranes determined by a simple competition assay. , 1990, Journal of immunological methods.

[89]  E. Podack,et al.  Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. , 1998, Journal of immunology.

[90]  L. Yu,et al.  The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. , 1999, Journal of immunology.

[91]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[92]  M. Peitsch,et al.  Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin , 1989, Nature.

[93]  S. Ohga,et al.  Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL) , 2006, Pediatric blood & cancer.

[94]  M. Aricò,et al.  Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. , 1998, Hematology/oncology clinics of North America.

[95]  J. D. Young,et al.  The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains , 1986, The Journal of experimental medicine.

[96]  A. Öst,et al.  Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis , 1991, Acta paediatrica Scandinavica.

[97]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[98]  C. Pignata,et al.  Role of A91V mutation in perforin gene in hemophagocytic lymphohistiocytosis , 2004 .

[99]  G. Janka,et al.  Familial hemophagocytic lymphohistiocytosis , 1983, European Journal of Pediatrics.

[100]  T. Mak,et al.  Homeostatic regulation of CD8+ T cells by perforin , 1999, European journal of immunology.

[101]  A. Saunders,et al.  A molecular genetic linkage map of mouse chromosome 7. , 1990, Genomics.

[102]  J. Trapani,et al.  Calcium-dependent Plasma Membrane Binding and Cell Lysis by Perforin Are Mediated through Its C2 Domain , 2005, Journal of Biological Chemistry.

[103]  A. Fischer,et al.  Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis , 2002, British journal of haematology.

[104]  A. Fischer,et al.  Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3) , 2003, Cell.

[105]  D. Green,et al.  Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid , 2000, Molecular and Cellular Biology.

[106]  S. Landolfo,et al.  Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection , 2000, European journal of immunology.

[107]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[108]  S. Ohga,et al.  Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. , 2005, Critical reviews in oncology/hematology.

[109]  J. Trapani,et al.  Immune surveillance of lymphoma in humans , 2005 .

[110]  M. Lovett,et al.  Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.

[111]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[112]  P. Bork,et al.  Identification and mutation analysis of the complete gene for Chediak–Higashi syndrome , 1996, Nature Genetics.

[113]  Craig W. Reynolds,et al.  Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors , 1984, The Journal of experimental medicine.

[114]  M. Zvelebil,et al.  Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domain , 1997, The EMBO journal.

[115]  J. Trapani,et al.  Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. , 2003, Immunity.

[116]  J. Shiver,et al.  Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A , 1992, Cell.

[117]  J. D. Young,et al.  Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin) , 1987, The Journal of experimental medicine.

[118]  J. Tschopp,et al.  Inhibition of the lytic activity of perforin by lipoproteins. , 1986, Journal of immunology.

[119]  M. Smyth,et al.  Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells , 2004, The Journal of experimental medicine.

[120]  H. Hennies,et al.  Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A , 2006, Human mutation.

[121]  J. Trapani,et al.  Granzyme M Mediates a Novel Form of Perforin-dependent Cell Death* , 2004, Journal of Biological Chemistry.

[122]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Falke,et al.  The C2 domain calcium‐binding motif: Structural and functional diversity , 1996, Protein science : a publication of the Protein Society.

[124]  Gillian M. Griffiths,et al.  Delivering the kiss of death , 2003, Nature Immunology.

[125]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[126]  F. Rieux-Laucat,et al.  Autoimmune lymphoproliferative syndrome and perforin. , 2005, The New England journal of medicine.

[127]  A. Greenberg,et al.  The influence of calcium, sodium, and the Na+/Ca2+ antiport on susceptibility to cytolysin/perforin-mediated cytolysis. , 1990, Journal of Immunology.

[128]  H. Takada,et al.  Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. , 2005, Blood.

[129]  D. Marmer,et al.  Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. , 2002, Blood.

[130]  J. Tschopp,et al.  Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. , 1985, The Journal of biological chemistry.

[131]  J. Trapani,et al.  The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) Gene , 2004, The Journal of experimental medicine.

[132]  R. Zinkernagel,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[133]  J. Shiver,et al.  A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene , 1991, Cell.

[134]  J. D. Young,et al.  Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[135]  P. Sham,et al.  Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. , 1999, American journal of human genetics.

[136]  J. D. Young,et al.  The primary structure of the lymphocyte pore-forming protein perforin: partial amino acid sequencing and determination of isoelectric point. , 1988, Biochemical and biophysical research communications.

[137]  J. Trapani,et al.  Granzyme B: pro-apoptotic, antiviral and antitumor functions. , 2003, Current opinion in immunology.

[138]  A. Brunger,et al.  Crystal Structure of the Cytosolic C2a-C2b Domains of Synaptotagmin III , 1999, The Journal of cell biology.

[139]  J. Cohen,et al.  Perforin and lymphohistiocytic proliferative disorders , 2005, British journal of haematology.